Avanos Medical Inc
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including… Read more
Market Cap & Net Worth: Avanos Medical Inc (AVNS)
Avanos Medical Inc (NYSE:AVNS) has a market capitalization of $632.91 Million ($632.91 Million) as of March 19, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #9584 globally and #4589 in its home market, demonstrating a 3.73% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Avanos Medical Inc's stock price $13.61 by its total outstanding shares 46503458 (46.50 Million).
Avanos Medical Inc Market Cap History: 2015 to 2026
Avanos Medical Inc's market capitalization history from 2015 to 2026. Data shows change from $1.55 Billion to $632.91 Million (-6.95% CAGR).
Index Memberships
Avanos Medical Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Small-Cap 600 Index
SML
|
$1.36 Trillion | 0.05% | #502 of 602 |
Weight: Avanos Medical Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Avanos Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Avanos Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.74x
Avanos Medical Inc's market cap is 0.74 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.72 Billion | $566.20 Million | $39.80 Million | 3.04x | 43.21x |
| 2017 | $2.15 Billion | $611.60 Million | $79.30 Million | 3.51x | 27.08x |
| 2018 | $2.08 Billion | $652.30 Million | $57.50 Million | 3.19x | 36.22x |
| 2019 | $1.57 Billion | $697.60 Million | -$45.90 Million | 2.25x | N/A |
| 2020 | $2.13 Billion | $714.80 Million | -$27.20 Million | 2.98x | N/A |
| 2021 | $1.61 Billion | $744.60 Million | $6.30 Million | 2.17x | 255.92x |
| 2022 | $1.26 Billion | $684.10 Million | $50.50 Million | 1.84x | 24.92x |
| 2023 | $1.04 Billion | $673.30 Million | -$61.80 Million | 1.55x | N/A |
| 2024 | $740.34 Million | $687.80 Million | -$392.10 Million | 1.08x | N/A |
| 2025 | $522.23 Million | $701.20 Million | -$67.90 Million | 0.74x | N/A |
Competitor Companies of AVNS by Market Capitalization
Companies near Avanos Medical Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Avanos Medical Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Avanos Medical Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Avanos Medical Inc's market cap moved from $1.55 Billion to $ 632.91 Million, with a yearly change of -6.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $632.91 Million | +21.19% |
| 2025 | $522.23 Million | -29.46% |
| 2024 | $740.34 Million | -29.02% |
| 2023 | $1.04 Billion | -17.11% |
| 2022 | $1.26 Billion | -21.95% |
| 2021 | $1.61 Billion | -24.43% |
| 2020 | $2.13 Billion | +36.14% |
| 2019 | $1.57 Billion | -24.76% |
| 2018 | $2.08 Billion | -3.01% |
| 2017 | $2.15 Billion | +24.88% |
| 2016 | $1.72 Billion | +10.69% |
| 2015 | $1.55 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Avanos Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $632.91 Million USD |
| MoneyControl | $632.91 Million USD |
| MarketWatch | $632.91 Million USD |
| marketcap.company | $632.91 Million USD |
| Reuters | $632.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.